Cases & Deals

Loxo Oncology acquires drug development program from administrators of RedX

Clients Loxo Oncology, Inc.

Jones Day advised biopharmaceutical company, Loxo Oncology, Inc., in connection with its $40 million acquisition of a drug development program aimed at treating leukemia from the administrators of RedX Pharma Plc.